624
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluations

Pazopanib for the treatment of renal cancer

&
Pages 1171-1189 | Published online: 07 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bernard Escudier & Laurence Albiges. (2014) Pazopanib for the treatment of advanced renal cell cancer. Expert Opinion on Orphan Drugs 2:6, pages 605-616.
Read now

Articles from other publishers (10)

Hai-Hao Han, Han-Min Wang, Paramesh Jangili, Mingle Li, Luling Wu, Yi Zang, Adam C. Sedgwick, Jia Li, Xiao-Peng He, Tony D. James & Jong Seung Kim. (2023) The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy. Chemical Society Reviews 52:3, pages 879-920.
Crossref
S. Sriharikrishnaa, Padmanaban S. Suresh & Shama Prasada K.. 2023. Optical Polarimetric Modalities for Biomedical Research. Optical Polarimetric Modalities for Biomedical Research 307 330 .
Cristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, Giuseppe Procopio, Ugo de Giorgi, Sebastiano Buti, Sabrina Rossetti, Roberto Iacovelli, Francesco Atzori, Laura Cosmai, Francesca Vignani, Giuseppe Prati, Sarah Scagliarini, Annalisa Guida, Annalisa Berselli & Carmine Pinto. (2019) Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study. Clinical Genitourinary Cancer 17:1, pages e150-e155.
Crossref
Dinesh Kumar Chellappan, Jestin Chellian, Zhao Yin Ng, Yan Jinn Sim, Chiu Wei Theng, Joyce Ling, Mei Wong, Jia Hui Foo, Goh Jun Yang, Li Yu Hang, Saranyah Nathan, Yogendra Singh & Gaurav Gupta. (2017) The role of pazopanib on tumour angiogenesis and in the management of cancers: A review. Biomedicine & Pharmacotherapy 96, pages 768-781.
Crossref
Mélanie Guyot & Gilles Pagès. 2015. VEGF Signaling. VEGF Signaling 3 23 .
Hong-Lin Zhao, Fan Yang, Xin Huang & Qing-Hua Zhou. (2014) Overview of fundamental study of pazopanib in cancer. Thoracic Cancer 5:6, pages 487-493.
Crossref
Jane Mattei, Rodrigo Donalisio da Silva, David Sehrt, Wilson R. Molina & Fernando J. Kim. (2014) Targeted therapy in metastatic renal carcinoma. Cancer Letters 343:2, pages 156-160.
Crossref
Mercè Juliachs, August Vidal, Xavier Garcia del Muro, Josep M Piulats, Enric Condom, Oriol Casanovas, Mariona Graupera, Jose R Germà, Alberto Villanueva & Francesc Viñals. (2013) Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors. BMC Cancer 13:1.
Crossref
Mhd Y. Al-Marrawi, Brian I. Rini, Lauren C. Harshman, Georg Bjarnason, Lori Wood, Ulka Vaishampayan, Mary MacKenzie, Jennifer J. Knox, Neeraj Agarwal, Hulayel Al-Harbi, Christian Kollmannsberger, Min-Han Tan, Sun Young Rha, Frede N. Donskov, Scott North, Toni K. Choueiri & Daniel Y. Heng. (2013) The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients. Targeted Oncology 8:3, pages 203-209.
Crossref
Bernd Kasper & Peter Hohenberger. (2011) Pazopanib: a promising new agent in the treatment of soft tissue sarcomas. Future Oncology 7:12, pages 1373-1383.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.